Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verkerk

Showing results (751-760 of 778) with videos related to

Pageof 78
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 15, 2023
Withdrawn as duplicate: Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature reviewHeidi Schigt, Martin Bald, Bram C J van der Eerden, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery ProtocolFlorentine A J Verbeek, Miguel P Martinez, Ilse A C Spiekman, et al.
Circulation Research|June 7, 2021
Targeting the Microtubule EB1-CLASP2 Complex Modulates Na<sub>V</sub>1.5 at Intercalated DiscsGerard A Marchal, Mariam Jouni, David Y Chiang, et al.
American Journal of Human Genetics|June 30, 2009
Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsyAnnemieke J M H Verkerk, Rachel Schot, Belinda Dumee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2024
Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fracturesWei Zhou, Joel Ås, Catherine Shore-Lorenti, et al.
The Lancet Regional Health. Europe|March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolKarlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)Ilse A C Spiekman, Laurien J Zeverijn, Birgit S Geurts, et al.
Scientific Reports|July 28, 2018
Identification of an I<sub>Na</sub>-dependent and I<sub>to</sub>-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patientDongrui Ma, Zhenfeng Liu, Li Jun Loh, et al.
Nature Biomedical Engineering|January 7, 2022
Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillationNiels Harlaar, Sven O Dekker, Juan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
Pageof 78

Showing results (751-760 of 778) with videos related to

Sort By:
Pageof 78
The Journal of Clinical Endocrinology and Metabolism|March 15, 2023
Withdrawn as duplicate: Expanding the phenotypic spectrum of Kenny-Caffey syndrome: a case series and systematic literature reviewHeidi Schigt, Martin Bald, Bram C J van der Eerden, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery ProtocolFlorentine A J Verbeek, Miguel P Martinez, Ilse A C Spiekman, et al.
Circulation Research|June 7, 2021
Targeting the Microtubule EB1-CLASP2 Complex Modulates Na<sub>V</sub>1.5 at Intercalated DiscsGerard A Marchal, Mariam Jouni, David Y Chiang, et al.
American Journal of Human Genetics|June 30, 2009
Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsyAnnemieke J M H Verkerk, Rachel Schot, Belinda Dumee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2024
Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fracturesWei Zhou, Joel Ås, Catherine Shore-Lorenti, et al.
The Lancet Regional Health. Europe|March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolKarlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)Ilse A C Spiekman, Laurien J Zeverijn, Birgit S Geurts, et al.
Scientific Reports|July 28, 2018
Identification of an I<sub>Na</sub>-dependent and I<sub>to</sub>-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patientDongrui Ma, Zhenfeng Liu, Li Jun Loh, et al.
Nature Biomedical Engineering|January 7, 2022
Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillationNiels Harlaar, Sven O Dekker, Juan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
Pageof 78